低肌肉量头颈癌患者治疗耐受性差
前瞻性队列纳入127例需微血管重建的可手术头颈鳞癌患者,用术前颈部CT计算颈椎旁骨骼肌指数(CPSMI)。低CPSMI与治疗耐受性差独立相关(OR 2.49,95%CI 1.10-5.93),并与辅助治疗延迟独立相关(OR 4.48,95%CI 1.07-27.6)。
要点
- 低CPSMI与可手术头颈鳞癌患者治疗耐受性差独立相关(OR 2.49,95%CI 1.10-5.93)。
- 低CPSMI与辅助治疗延迟独立相关(OR 4.48,95%CI 1.07-27.6)。
- 71例(56%)出现治疗耐受性差,其中21例未完成推荐辅助治疗、66例发生严重治疗相关并发症。
核心结论
- 低CPSMI与可手术头颈鳞癌患者的治疗耐受性差独立相关。
研究设计与样本
- 前瞻性队列研究,纳入127例需微血管重建的可手术黏膜头颈鳞状细胞癌(HNSCC)患者,平均年龄60.5岁,用术前颈部CT计算低颈椎旁骨骼肌指数(CPSMI)。
主要发现
- 127例患者接受切除手术,平均年龄60.5岁。
- 71例(56%)出现治疗耐受性差,其中21例未完成推荐辅助治疗,66例发生严重治疗相关并发症。
- 多因素校正后,低CPSMI与治疗耐受性差独立相关(OR 2.49,95%CI 1.10-5.93)。
- 多因素校正后,低CPSMI与辅助治疗延迟独立相关(OR 4.48,95%CI 1.07-27.6)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We ascertain the role of a low cervical paraspinal skeletal muscle index (CPSMI) as a biomarker for poor treatment tolerance in patients with operable mucosal head and neck squamous cell carcinoma (HNSCC). METHODS: A prospective cohort of patients with operable HNSCC requiring microvascular reconstruction was evaluated. Low CPSMI was calculated using preoperative CT neck imaging. Poor treatment tolerance, a composite measure of incomplete therapy or severe morbidity/mortality during treatment, was the primary outcome. RESULTS: One hundred and twenty-seven patients underwent extirpative surgery with a mean age was 60.5. Poor treatment tolerance occurred in 71 (56%) patients with 21 not completing recommended adjuvant therapy and 66 having severe treatment-related morbidity. A low CPSMI was independently associated with poor treatment tolerance (OR 2.49, 95%CI 1.10-5.93) and delay to adjuvant therapy (OR 4.48, 95%CI 1.07-27.6) after adjusting for multiple confounders. CONCLUSION: Low CPSMI was independently associated with poor treatment tolerance in patients with operable HNSCC.
引用
- Mascarella MA, Patel T, Vendra V, et al. Poor treatment tolerance in head and neck cancer patients with low muscle mass. Head Neck. 2022. PMID: 35020252. doi:10.1002/hed.26978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。